Stock listing

NASDAQ:QTRX Quanterix Corporation Stock

Home listing (NASDAQ) of Quanterix Corporation

Follow Quanterix Corporation into a list and get an email when it puts out news.

Share price · NASDAQ:QTRX

$1.96 USD -0.07 (-3.4%)

Close on Nov 20, 2026

Past year -66.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.78 – $2.03 USDNov 20, 2026
Volume
1.06M sharesNov 20, 2026
Market cap
$93.06M USDAt the close on Nov 20, 2026 · price × 47.48M shares outstanding
52-week range
$1.77 – $8.77 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$2.01M USDMedian day 506,100 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Quanterix Corporation logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:QTRX · Home$1.96 USD-0.07 (-3.4%)1,055,963$1.98$2.03$1.775$2.03Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:QTRX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.96-0.07-3.4%$1.98$2.03$1.7751,055,963
$2.03-0.04-1.9%$2.07$2.08$1.7652,129,295
$2.07-0.79-27.6%$2.43$2.59$2.0453,539,869
$2.86+0.02+0.7%$2.84$2.97$2.82499,644
$2.84-0.09-3.1%$2.90$2.92$2.715618,247
$2.93+0.07+2.4%$2.90$3.035$2.78394,300
$2.86-0.16-5.3%$2.98$3.10$2.855619,300
$3.02-0.26-7.9%$3.33$3.40$2.985507,100
$3.28-0.10-3.0%$3.42$3.53$3.18740,700
$3.38+0.485+16.8%$2.91$3.44$2.8271,175,600
$2.895+0.135+4.9%$2.81$2.93$2.78474,800
$2.76-0.28-9.2%$3.01$3.01$2.715357,300
$3.04+0.10+3.4%$2.99$3.13$2.925402,200
$2.94+0.13+4.6%$2.87$2.98$2.87266,900
$2.81-0.095-3.3%$2.94$2.94$2.735510,500
$2.905-0.24-7.6%$3.10$3.105$2.83361,300
$3.145+0.025+0.8%$3.11$3.21$3.095334,200
$3.12+0.23+8.0%$2.87$3.12$2.84658,100
$2.89+0.06+2.1%$2.86$2.96$2.82467,700
$2.83-0.03-1.0%$2.86$2.896$2.79257,100
$2.86+0.02+0.7%$2.82$2.88$2.71349,800
$2.84+0.05+1.8%$2.74$2.895$2.71496,300
$2.79+0.07+2.6%$2.71$2.815$2.675525,200
$2.72-0.05-1.8%$2.77$2.845$2.71536,400
$2.77-0.10-3.5%$2.87$2.93$2.72430,100
$2.87-0.20-6.5%$3.07$3.07$2.835322,600
$3.07+0.01+0.3%$3.05$3.105$2.92291,100
$3.06-0.09-2.9%$3.10$3.23$3.05342,300
$3.15-0.01-0.3%$3.17$3.335$3.11749,900
$3.16-0.12-3.7%$3.28$3.35$3.07562,800
$3.28+0.07+2.2%$3.22$3.445$3.20282,600
$3.21-0.115-3.5%$3.25$3.25$3.061606,100
$3.325-0.115-3.3%$3.40$3.55$3.31493,500
$3.44-0.37-9.7%$3.83$3.98$3.42606,400
$3.81+0.17+4.7%$3.66$3.897$3.621,032,200
$3.64+0.23+6.7%$3.44$3.69$3.44590,800
$3.41-0.30-8.1%$3.72$3.72$3.375629,200
$3.71+0.04+1.1%$3.67$3.72$3.59545,300
$3.67+0.15+4.3%$3.52$3.71$3.454623,400
$3.52+0.25+7.6%$3.25$3.674$3.231,044,600
$3.27+0.09+2.8%$3.23$3.29$3.105563,500
$3.18+0.02+0.6%$3.15$3.22$3.041374,200
$3.16-0.03-0.9%$3.17$3.198$3.03423,700
$3.19+0.15+4.9%$3.05$3.21$3.03424,900
$3.04-0.03-1.0%$3.13$3.175$3.005627,400
$3.07-0.05-1.6%$3.12$3.14$3.001,048,100
$3.12+0.21+7.2%$2.94$3.19$2.90955,700
$2.91+0.19+7.0%$2.72$2.955$2.66924,900
$2.72+0.22+8.8%$2.50$2.79$2.4951,595,200
$2.50-0.06-2.3%$2.50$2.685$2.376,093,200
$2.56+0.06+2.4%$2.52$2.59$2.50323,000
$2.50-0.15-5.7%$2.60$2.625$2.49456,100
$2.65-0.08-2.9%$2.70$2.715$2.61266,200
$2.73+0.04+1.5%$2.64$2.83$2.61647,400
$2.69+0.11+4.3%$2.58$2.695$2.54274,600
$2.58-0.03-1.1%$2.63$2.64$2.43842,000
$2.61+0.10+4.0%$2.49$2.64$2.49459,000
$2.51-0.16-6.0%$2.59$2.62$2.50904,100
$2.67+0.03+1.1%$2.62$2.675$2.53401,300
$2.640.000.0%$2.64$2.67$2.58349,500
$2.64-0.04-1.5%$2.66$2.736$2.62413,000
$2.68-0.11-3.9%$2.83$2.86$2.65381,800
$2.79-0.01-0.4%$2.80$2.96$2.775505,100
$2.80-0.19-6.4%$2.99$3.00$2.752499,000
$2.99-0.13-4.2%$3.11$3.11$2.99321,200
$3.12+0.16+5.4%$2.96$3.25$2.86579,100
Ticker
NASDAQ:QTRX
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Quanterix Corporation news

Quanterix Corporation on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
33 in the last 12 months · 122 in all · newest Nov 18, 2026 · oldest 2019
Calls
22 calls with a replay · 22 with a transcript · latest Nov 9, 2026
Decks
47 decks · latest Nov 9, 2026

Where Quanterix Corporation is listed

ListingExchangeCountryCurrency
NASDAQ:QTRX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:QTRXBOATSUnited StatesUSD

Valuation

EV/sales 0.3× against a median of 3.0×: the lowest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$47.06M USD
P/E
Loss
EV/sales
0.3×
EV/EBITDA
Negative EBITDA
Price/book
0.4×
Gross margin
44.5%
Operating margin
−93.2%
Net margin
−75.0%
Debt to equity
0.1×
Beta vs S&P 500
1.87

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Quanterix Corporation · NASDAQ:QTRXUS$93.06MUS$47.06Mn/a0.3×n/a0.4×−75.0%0.1×1.87
Photocure ASA · OSL:PHOUS$113.9MUS$97.23M22.9×1.4×6.1×1.9×7.1%0.0×n/a
ArcticZymes Technologies ASA · OSL:AZTUS$108.4MUS$80.84M66.1×6.2×24.6×3.0×12.7%0.0×n/a
NanoenTek, Inc. · KRX:039860US$107.8MUS$71.26M24.8×2.2×17.4×1.5×13.3%0.0×n/a
BICO Group AB Class B · OMXSTO:BICOUS$102.7MUS$90.50Mn/a0.6×2.1×0.8×−28.3%0.3×n/a
Devyser Diagnostics AB · OMXSTO:DVYSRUS$99.24MUS$94.86M39.9×3.8×17.5×2.6×10.0%0.1×n/a
Exagen Inc. · NASDAQ:XGNUS$92.10MUS$86.82Mn/a1.2×n/a6.7×−25.1%1.7×2.52
Biodesix, Inc. · NASDAQ:BDSXUS$83.83MUS$105.4Mn/a1.0×n/a9.7×−25.7%5.8×1.56
Bonraybio Co. Ltd. · TWSE:6955US$81.85MUS$65.60M25.0×6.5×18.1×4.1×32.5%0.0×n/a
Nightingale Health Oyj Class B · OMXHEX:HEALTHUS$77.17MUS$36.79Mn/a6.1×n/a1.4×−335.7%0.0×n/a
Lucid Diagnostics Inc. · NASDAQ:LUCDUS$77.14MUS$77.63Mn/a14.3×n/a13.0×−892.8%3.1×1.36
Median of the othersUS$95.67MUS$83.83M25.0×3.0×17.5×2.8×−9.0%0.1×1.56

Forecasts

3 hold · Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.

Price target
3.17 USD · Analysts' mean
EPS, year to Dec 2026
-1.96 · 3 analysts
Revenue, year to Dec 2026
143.2M · 3 analysts

Team and board

Officers

OfficerRole
Jim GuteChief Commercial Officer and Interim President and CEO
Jason FaesslerChief Financial Officer
Ivana Magovčević-LiebischPresident
Anthony CatalanoChief Operating Officer
Jeffrey ElliottCOO of Exact Sciences
Daniel CharChief Legal Officer
Joshua YoungInvestor Relations
Bill DonnellyExecutive Chair of the Board, Director, Retired EVP, Mettler-Toledo International
Geoff AlbrechtSVP, General Manager, Diagnostics
Erica BellChief People Officer
Michael MillerChief Technology and Product Officer
Naren BhatChief Strategy Officer
Yuri FeskoChief Medical Officer

Board

DirectorRole
Bill DonnellyExecutive Chair of the Board, Director, Retired EVP, Mettler-Toledo International

Events

Calls

CallWhenStatus
Quanterix (NASDAQ:QTRX) Q3 2026 Earnings CallMon, Nov 09, 2026 · 8:30 AM ETReplay
Quanterix (NASDAQ:QTRX) Q2 2026 Earnings CallMon, Aug 10, 2026 · 8:30 AM ETReplay
Quanterix (NASDAQ:QTRX) Q1 2026 Earnings CallWed, May 06, 2026 · 4:30 PM ETReplay
Quanterix (NASDAQ:QTRX) Q3 2025 Earnings CallMon, Nov 10, 2025 · 4:30 PM ETReplay
Quanterix (NASDAQ:QTRX) Q2 2025 Earnings CallThu, Aug 07, 2025 · 4:30 AM ETReplay
Quanterix (NASDAQ:QTRX) Q1 2025 Earnings CallMon, May 12, 2025 · 5:30 PM ETReplay
Quanterix (NASDAQ:QTRX) Q4 2024 Earnings CallMon, Mar 17, 2025 · 4:30 PM ETReplay
Quanterix (NASDAQ:QTRX) Q3 2024 Earnings CallTue, Nov 12, 2024 · 4:30 PM ETReplay
Quanterix (NASDAQ:QTRX) Q2 2024 Earnings CallThu, Aug 08, 2024 · 4:30 PM ETReplay
Quanterix (NASDAQ:QTRX) Q1 2024 Earnings CallWed, May 08, 2024 · 8:30 AM ETReplay
All 22 calls
CallWhenStatus
Quanterix (NASDAQ:QTRX) Q4 2023 Earnings CallThu, Feb 29, 2024 · 4:30 PM ETReplay
Quanterix (NASDAQ:QTRX) Q3 2023 Earnings CallTue, Nov 07, 2023 · 8:30 AM ETReplay
Quanterix (NASDAQ:QTRX) Q2 2023 Earnings CallTue, Aug 08, 2023 · 8:30 AM ETReplay
Quanterix (NASDAQ:QTRX) Q1 2023 Earnings CallTue, May 09, 2023 · 4:30 PM ETReplay
Quanterix (NASDAQ:QTRX) Q4 2022 Earnings CallMon, Mar 06, 2023 · 8:30 AM ETReplay
Quanterix (NASDAQ:QTRX) Q3 2022 Earnings CallTue, Nov 08, 2022 · 4:30 PM ETReplay
Quanterix (NASDAQ:QTRX) Q2 2022 Earnings CallMon, Aug 08, 2022 · 4:30 PM ETReplay
Quanterix (NASDAQ:QTRX) Q1 2022 Earnings CallTue, May 10, 2022 · 8:30 AM ETReplay
Quanterix (NASDAQ:QTRX) Q4 2021 Earnings CallTue, Mar 01, 2022 · 8:30 AM ETReplay
Quanterix (NASDAQ:QTRX) Q3 2021 Earnings CallThu, Nov 04, 2021 · 4:30 PM ETReplay
Quanterix (NASDAQ:QTRX) Q2 2021 Earnings CallThu, Aug 05, 2021 · 4:30 PM ETReplay
Quanterix (NASDAQ:QTRX) Q3 2020 Earnings CallThu, Nov 05, 2020 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 9, 2026 · Before open+16.8%
Q2 2026Aug 10, 2026 · Before open−40.0%
Q1 2026May 6, 2026 · After close−16.4%
Q4 2025Mar 3, 2026−7.4%
Q3 2025Nov 10, 2025 · After close−2.3%
Q2 2025Aug 7, 2025 · After close−13.8%
Q1 2025May 12, 2025 · After close−19.0%
Q4 2024Feb 26, 2025 · Before open+1.5%
Q3 2024Dec 26, 2024 · Before open+5.2%
Q2 2024Aug 8, 2024 · After close−14.8%
All 20 quarters
QuarterResultsShare move
Q1 2024May 7, 2024 · After close−4.9%
Q4 2023Feb 29, 2024 · After close+12.7%
Q3 2023Nov 6, 2023 · After close+2.2%
Q2 2023Aug 7, 2023 · After close+16.9%
Q1 2023May 9, 2023 · After close+0.6%
Q4 2022Mar 6, 2023 · Before open+12.1%
Q3 2022Nov 8, 2022 · After close+1.3%
Q2 2022Aug 8, 2022 · After close−54.8%
Q1 2022May 10, 2022 · After close−8.3%
Q4 2021Mar 1, 2022 · Before open−6.3%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings21 slidesNov 9, 2026
Q2 2026 Earnings PresentationEarnings21 slidesAug 10, 2026
Q1 2026 Earnings PresentationEarnings17 slidesMay 6, 2026
FY2025 Earnings PresentationEarnings14 slidesMar 2, 2026
Q3 2025 Earnings PresentationEarnings11 slidesNov 10, 2025
Q2 2025 Earnings PresentationEarnings12 slidesAug 7, 2025
Q1 2025 Earnings PresentationEarnings19 slidesMay 12, 2025
Proxy Contest (April 2025)Proxy contest8 slidesApr 21, 2025
Q4 2024 Earnings PresentationEarnings15 slidesMar 17, 2025
J.P. Morgan Healthcare Conference 2025Conference31 slidesJan 15, 2025
All 47 decks
DeckKindSlidesDate
Merger or Acquisition (January 2025)Merger or acquisition15 slidesJan 10, 2025
Corporate Update (December 2024)Corporate update5 slidesDec 23, 2024
Q3 2024 Earnings PresentationEarnings11 slidesNov 12, 2024
Q2 2024 Earnings PresentationEarnings12 slidesAug 8, 2024
Q1 2024 Earnings PresentationEarnings10 slidesMay 8, 2024
Q4 2023 Earnings PresentationEarnings16 slidesFeb 29, 2024
J.P. Morgan Healthcare Conference 2024Conference23 slidesJan 10, 2024
Q3 2023 Earnings PresentationEarnings10 slidesNov 7, 2023
Q2 2023 Earnings PresentationEarnings12 slidesAug 8, 2023
Q1 2023 Earnings PresentationEarnings11 slidesMay 9, 2023
Q4 2022 Earnings PresentationEarnings13 slidesMar 6, 2023
Barclays Global Healthcare Conference 2023Conference30 slides2023
J.P. Morgan Healthcare Conference 2023Conference25 slidesJanuary 2023
Q3 2022 Earnings PresentationEarnings10 slidesNov 8, 2022
Q2 2022 Earnings PresentationEarnings13 slidesAug 8, 2022
Q1 2022 Earnings PresentationEarnings8 slidesMay 10, 2022
Q4 2021 Earnings PresentationEarnings44 slidesMar 1, 2022
Q3 2021 Earnings PresentationEarnings30 slidesNov 4, 2021
Q2 2021 Earnings PresentationEarnings31 slidesAug 5, 2021
Q1 2021 Earnings PresentationEarnings32 slidesMay 5, 2021
Q4 2020 Earnings PresentationEarnings74 slidesMar 2, 2021
Q3 2020 Earnings PresentationEarnings52 slidesNov 5, 2020
Q2 2020 Earnings PresentationEarnings35 slidesAug 4, 2020
Q1 2020 Earnings PresentationEarnings34 slidesMay 5, 2020
Q4 2019 Earnings PresentationEarnings30 slidesMar 9, 2020
Q3 2019 Earnings PresentationEarnings27 slidesNov 6, 2019
Q2 2019 Earnings PresentationEarnings24 slidesAug 6, 2019
Q4 2018 Earnings PresentationEarnings26 slidesMar 7, 2019
Q1 2019 Earnings PresentationEarnings35 slides2019
J.P. Morgan Healthcare Conference 2018Conference29 slidesJanuary 2018
Technical Presentation (October 2015)Technical18 slidesOct 29, 2015
Technical Presentation (October 2015)Technical20 slidesOct 29, 2015
Technical Presentation (October 2015)Technical34 slidesOct 29, 2015
Proteins Powering NexGen Healthcare, San Francisco Conference (October 2015)Conference68 slidesOct 29, 2015
Technical Presentation (October 2015)Technical26 slidesOctober 2015
Technical Presentation (September 2015)Technical40 slidesSeptember 2015
Technical Presentation (June 2015)Technical24 slidesJun 9, 2015

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue138.9M137.4M122.4M105.5M110.6M86.4M56.7M37.6M22.9M17.6M
Cost of revenue73.9M54.3M48.1M60.2M45.8M38.2M29.9M19.7M12.9M9.84M
Gross profit65.0M83.1M74.2M45.4M64.8M48.2M26.8M17.9M9.99M7.75M
Research and development35.9M31.1M26.1M26.8M28.4M20.2M16.2M15.8M16.3M17.0M
Selling, general and administrative138.0M101.6M89.1M91.9M92.9M59.6M52.2M33.7M19.7M12.5M
Operating income-125.5M-52.6M-46.0M-104.3M-56.5M-31.6M-41.6M-31.6M-26.0M-21.7M
Depreciation and amortization15.8M6.46M6.28M5.41M4.88M4.31M3.01M1.35M482.0K444.0K
EBITDA-109.7M-46.2M-39.7M-98.9M-51.6M-27.3M-38.6M-30.2M-25.5M-21.3M
Interest expense15.8M5.13M403.0K273.0K627.0K46.0K952.0K1.30M
Income before tax-112.3M-38.1M-27.6M-99.4M-55.6M-31.9M-41.0M-31.5M-27.0M-23.2M
Income tax-5.12M434.0K719.0K164.0K-36.0K-376.0K-187.0K25.0K01.13M
Net income-107.2M-38.5M-28.4M-99.6M-55.5M-31.5M-40.8M-31.5M-27.0M-23.2M
Earnings per share, basic-2.51-1.00-0.75-2.69-1.54-1.07-1.63-1.41-1.24-0.82
Earnings per share, diluted-2.51-1.00-0.75-2.69-1.54-1.07-1.63

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents29.8M56.7M174.4M338.7M396.5M181.6M109.2M44.4M79.7M29.7M
Short-term investments88.4M06.89M0
Receivables30.0M32.1M25.4M19.0M23.8M17.2M10.9M6.79M5.60M3.92M
Inventory54.8M32.8M26.1M17.0M22.2M14.9M10.5M5.95M3.57M1.53M
Current assets212.3M363.6M382.1M381.5M449.0M219.6M132.7M59.5M89.3M35.2M
Property, plant and equipment23.7M17.1M17.9M19.8M18.0M13.9M12.0M2.92M1.87M1.22M
Goodwill26.4M0009.63M10.5M9.35M1.31M
Total assets418.8M406.5M428.6M433.6M501.5M271.0M170.0M67.6M91.8M37.1M
Accounts payable13.6M6.95M5.05M3.84M9.21M6.80M5.78M5.11M3.55M2.55M
Current liabilities74.8M42.0M39.0M31.3M37.0M39.8M19.8M18.1M19.7M11.0M
Long-term debt7.59M7.62M4.35M9.34M
Total debt37.2M37.4M41.5M44.1M21.9M7.69M7.69M7.76M9.38M13.0M
Total liabilities123.0M76.5M78.6M75.7M60.6M64.9M41.3M26.5M25.9M23.6M
Shareholders' equity295.7M330.0M350.0M357.9M442.8M205.8M128.7M41.1M65.9M-115.1M
Shares outstanding46.7M38.6M38.0M37.3M36.8M31.8M28.1M22.4M21.7M28.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-77.2M-35.2M-18.8M-48.6M-47.6M-23.4M-26.2M-28.7M-22.1M-17.7M
Capital spending-2.61M-3.37M-3.84M-11.6M-13.7M-3.93M-10.8M-1.52M-1.13M-526.0K
Free cash flow-79.8M-38.5M-22.7M-60.2M-61.3M-27.3M-37.0M-30.2M-23.2M-18.3M
Cash from investing50.2M-82.3M-148.5M-11.1M-6.40M-626.0K-25.4M-5.45M-1.13M-826.0K
Cash from financing-708.0K456.0K2.69M2.31M270.8M96.2M116.2M-78.0K73.2M45.9M
Share buybacks-198.0K2.31M278.5M96.3M116.2M-20.0K74.2M45.7M
Change in cash-27.7M-117.0M-164.6M-57.2M216.6M72.2M64.6M-34.3M50.0M27.3M

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 18, 2026Management or board changeSEC
4 · Change in ownershipNov 17, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 10, 2026Big-stake noticeSEC
10-Q · Quarterly reportNov 9, 2026Quarterly reportSEC
8-K · Current reportNov 9, 2026ResultsSEC
4 · Change in ownershipOct 16, 2026Insider tradeSEC
4 · Change in ownershipOct 2, 2026Insider tradeSEC
4 · Change in ownershipOct 2, 2026Insider tradeSEC
4 · Change in ownershipOct 2, 2026Insider tradeSEC
4 · Change in ownershipSep 17, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipSep 16, 2026Insider tradeSEC
S-8 · Registration statement for employee plansSep 10, 2026Offer documentSEC
4 · Change in ownershipSep 1, 2026Insider tradeSEC
4 · Change in ownershipAug 20, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 19, 2026Insider tradeSEC
4 · Change in ownershipAug 19, 2026Insider tradeSEC
4 · Change in ownershipAug 17, 2026Insider tradeSEC
4 · Change in ownershipAug 14, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
10-Q · Quarterly reportAug 10, 2026Quarterly reportSEC
8-K · Current reportAug 10, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeAug 6, 2026Big-stake noticeSEC
4 · Change in ownershipAug 4, 2026Insider tradeSEC
4 · Change in ownershipJul 16, 2026Insider tradeSEC
4 · Change in ownershipJul 16, 2026Insider tradeSEC
4 · Change in ownershipJul 9, 2026Insider tradeSEC
4 · Change in ownershipJul 9, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
3 · Initial statement of ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 16, 2026Insider tradeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
3 · Initial statement of ownershipJun 12, 2026Insider tradeSEC
8-K · Current reportJun 10, 2026Meeting outcomeSEC
8-K · Current reportJun 9, 2026Management or board changeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
8-K · Current reportMay 26, 2026Management or board changeSEC
4 · Change in ownershipMay 18, 2026Insider tradeSEC
4 · Change in ownershipMay 18, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
8-K · Current reportMay 12, 2026Management or board changeSEC
DEFA14A · Additional proxy materialMay 8, 2026Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 7, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 6, 2026Quarterly reportSEC
8-K · Current reportMay 6, 2026ResultsSEC
4 · Change in ownershipMay 1, 2026Insider tradeSEC
ARS · Annual report to shareholdersApr 24, 2026Annual reportSEC
DEF 14A · Proxy statementApr 24, 2026Meeting noticeSEC
4 · Change in ownershipApr 17, 2026Insider tradeSEC
4 · Change in ownershipApr 17, 2026Insider tradeSEC
4 · Change in ownershipApr 7, 2026Insider tradeSEC
4 · Change in ownershipApr 7, 2026Insider tradeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 27, 2026Big-stake noticeSEC
3 · Initial statement of ownershipMar 24, 2026Insider tradeSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 17, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
S-8 · Registration statement for employee plansMar 5, 2026Offer documentSEC
10-K · Annual reportMar 2, 2026Annual reportSEC
8-K · Current reportMar 2, 2026ResultsSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
4 · Change in ownershipJan 21, 2026Insider tradeSEC
3 · Initial statement of ownershipJan 21, 2026Insider tradeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
S-8 · Registration statement for employee plansJan 15, 2026Offer documentSEC
4 · Change in ownershipJan 15, 2026Insider tradeSEC
4 · Change in ownershipJan 15, 2026Insider tradeSEC
4 · Change in ownershipJan 14, 2026Insider tradeSEC
8-K · Current reportJan 8, 2026ResultsSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
S-8 · Registration statement for employee plansDec 22, 2025Offer documentSEC
4 · Change in ownershipDec 18, 2025Insider tradeSEC
4 · Change in ownershipDec 18, 2025Insider tradeSEC
4 · Change in ownershipDec 8, 2025Insider tradeSEC
3 · Initial statement of ownershipDec 8, 2025Insider tradeSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
3 · Initial statement of ownershipNov 25, 2025Insider tradeSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
8-K · Current reportNov 20, 2025Management or board changeSEC
SCHEDULE 13G · Big-stake noticeNov 19, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportNov 10, 2025Quarterly reportSEC
8-K · Current reportNov 10, 2025ResultsSEC
4 · Change in ownershipNov 5, 2025Insider tradeSEC
4 · Change in ownershipOct 17, 2025Insider tradeSEC
4 · Change in ownershipOct 17, 2025Insider tradeSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
4 · Change in ownershipOct 2, 2025Insider tradeSEC
8-K · Current reportOct 2, 2025Meeting outcomeSEC
DEFA14A · Additional proxy materialSep 23, 2025Meeting noticeSEC
8-K · Current reportSep 23, 2025Meeting outcomeSEC
8-K/A · Current report, amendedSep 23, 2025Current reportSEC
4 · Change in ownershipSep 17, 2025Insider tradeSEC
4 · Change in ownershipSep 17, 2025Insider tradeSEC
4 · Change in ownershipSep 17, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
ARS · Annual report to shareholdersAug 25, 2025Annual reportSEC
DEF 14A · Proxy statementAug 25, 2025Meeting noticeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 13, 2025Big-stake noticeSEC
PRE 14A · Preliminary proxy statementAug 8, 2025Meeting noticeSEC
10-Q · Quarterly reportAug 7, 2025Quarterly reportSEC
8-K · Current reportAug 7, 2025ResultsSEC
8-K · Current reportAug 4, 2025Material contractSEC
4 · Change in ownershipAug 4, 2025Insider tradeSEC
8-K · Current reportJul 24, 2025Current reportSEC
8-K · Current reportJul 18, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 17, 2025Big-stake noticeSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 15, 2025Big-stake noticeSEC
S-8 POSJul 11, 2025Offer documentSEC
S-8 · Registration statement for employee plansJul 11, 2025Offer documentSEC
4 · Change in ownershipJul 10, 2025Insider tradeSEC
4 · Change in ownershipJul 10, 2025Insider tradeSEC
3 · Initial statement of ownershipJul 9, 2025Insider tradeSEC
3 · Initial statement of ownershipJul 9, 2025Insider tradeSEC
8-K · Current reportJul 8, 2025Acquisition or disposalSEC
4 · Change in ownershipJul 3, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
8-K · Current reportJul 1, 2025Current reportSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
424B3 · ProspectusJun 13, 2025Offer documentSEC
4 · Change in ownershipJun 13, 2025Insider tradeSEC
EFFECT · Notice that a registration is effectiveJun 13, 2025Other filingsSEC
CORRESP · Letter to the SECJun 11, 2025Other filingsSEC
DFAN14AJun 11, 2025Other filingsSEC
4 · Change in ownershipJun 10, 2025Insider tradeSEC
4 · Change in ownershipJun 9, 2025Insider tradeSEC
4 · Change in ownershipJun 9, 2025Insider tradeSEC
CORRESP · Letter to the SECJun 3, 2025Other filingsSEC
POS AM · Amendment to an effective registrationJun 3, 2025Offer documentSEC
4 · Change in ownershipJun 3, 2025Insider tradeSEC
SD · Specialized disclosureJun 2, 2025ESG reportSEC
UPLOAD · Letter from the SECMay 30, 2025Other filingsSEC
DFAN14AMay 23, 2025Other filingsSEC
POS AM · Amendment to an effective registrationMay 20, 2025Offer documentSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2025Big-stake noticeSEC
8-K · Current reportMay 14, 2025Current reportSEC
10-Q · Quarterly reportMay 12, 2025Quarterly reportSEC
425May 12, 2025Other filingsSEC
8-K · Current reportMay 12, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 7, 2025Big-stake noticeSEC
4 · Change in ownershipMay 2, 2025Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedApr 30, 2025Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedApr 30, 2025Big-stake noticeSEC
10-K/A · Annual report, amendedApr 30, 2025Annual reportSEC
DFAN14AApr 30, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 30, 2025Big-stake noticeSEC
425Apr 29, 2025Other filingsSEC
8-K · Current reportApr 29, 2025Material contractSEC
DFAN14AApr 24, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 23, 2025Big-stake noticeSEC
DFAN14AApr 22, 2025Other filingsSEC
DFAN14AApr 21, 2025Other filingsSEC
DFAN14AApr 18, 2025Other filingsSEC
4 · Change in ownershipApr 17, 2025Insider tradeSEC
4 · Change in ownershipApr 17, 2025Insider tradeSEC
DEFC14AApr 17, 2025Other filingsSEC
424B3 · ProspectusApr 15, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveApr 15, 2025Other filingsSEC
CORRESP · Letter to the SECApr 11, 2025Other filingsSEC
CORRESP · Letter to the SECApr 10, 2025Other filingsSEC
CORRESP · Letter to the SECApr 10, 2025Other filingsSEC
S-4/A · Registration statement, amendedApr 10, 2025Offer documentSEC
UPLOAD · Letter from the SECApr 9, 2025Other filingsSEC
DFAN14AApr 7, 2025Other filingsSEC
UPLOAD · Letter from the SECApr 7, 2025Other filingsSEC
S-4/A · Registration statement, amendedApr 4, 2025Offer documentSEC
8-K · Current reportApr 4, 2025Material contractSEC
425Apr 4, 2025Other filingsSEC

This page holds 200 of 1,001 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Quanterix Corporation’s releases · as of Nov 2, 2026

Common shares
47,478,422
Fully diluted
47,478,422

Fully diluted

LineSharesAs of
Common shares47,478,422Nov 2, 2026

Share count over time

CountShares
Nov 2, 202647,478,422

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
BlackRock3.76M7.9%US$14MSep 30, 2026
Blue Water Life Science Advisors, LP3.47M7.3%US$12.9MSep 30, 2026
Vanguard2.66M5.6%US$9.85MSep 30, 2026
First Eagle Investment Management, LLC2.19M4.6%US$8.13MSep 30, 2026
Portolan Capital Management, LLC1.84M3.9%US$6.83MSep 30, 2026
Lionhunter Capital Management, LLC1.72M3.6%US$6.39MSep 30, 2026
Marshall Wace, LLP1.19M2.5%US$4.43MSep 30, 2026
Geode Capital1.13M2.4%US$4.2MSep 30, 2026
State Street901K1.9%US$3.34MSep 30, 2026
Prosight Management, LP825K1.7%US$3.06MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
AQR Capital Management LLC786K1.7%US$2.92MSep 30, 2026
Citadel740K1.6%US$2.75MSep 30, 2026
Morgan Stanley646K1.4%US$2.4MSep 30, 2026
Tikvah Management LLC572K1.2%US$2.12MSep 30, 2026
Goldman Sachs527K1.1%US$1.95MSep 30, 2026
Gsa Capital Partners LLP495K1.0%US$1.83MSep 30, 2026
Tudor Investment Corp Et Al473K1.00%US$1.75MSep 30, 2026
UBS471K0.99%US$1.75MSep 30, 2026
Jacobs Levy Equity Management, Inc345K0.73%US$1.28MSep 30, 2026
Walleye Capital LLC332K0.70%US$1.23MSep 30, 2026
Northern Trust326K0.69%US$1.21MSep 30, 2026
Dimensional305K0.64%US$1.13MSep 30, 2026
Jane Street242K0.51%US$896KSep 30, 2026
Fidelity241K0.51%US$893KSep 30, 2026
Susquehanna235K0.50%US$872KSep 30, 2026
Point72 Asset Management, L.P.214K0.45%US$793KSep 30, 2026
Nuveen208K0.44%US$772KSep 30, 2026
XTX Topco Ltd206K0.43%US$764KSep 30, 2026
Invesco168K0.35%US$622KSep 30, 2026
Ironwood Investment Management LLC167K0.35%US$621KSep 30, 2026
Renaissance Technologies166K0.35%US$617KSep 30, 2026
Jump Financial, LLC158K0.33%US$586KSep 30, 2026
Schwab154K0.33%US$573KSep 30, 2026
BNY147K0.31%US$545KSep 30, 2026
Wells Fargo122K0.26%US$452KSep 30, 2026
Bank of America120K0.25%US$446KSep 30, 2026
SCS Capital Management LLC120K0.25%US$445KSep 30, 2026
American Century100K0.21%US$373KSep 30, 2026
T. Rowe Price95,6260.20%US$355KSep 30, 2026
JPMorgan70,6260.15%US$259KSep 30, 2026
CPP Investments64,6000.14%US$240KSep 30, 2026
Clearstead Advisors, LLC62,0680.13%US$230KSep 30, 2026
AllianceBernstein56,7800.12%US$211KSep 30, 2026
Peddock Capital Advisors, LLC52,1050.11%US$193KSep 30, 2026
Rhumbline Advisers51,6250.11%US$192KSep 30, 2026
Hrt Financial LP51,4310.11%US$190KSep 30, 2026
Russell Investments Group, Ltd.50,5140.11%US$187KSep 30, 2026
Bridgeway Capital Management, LLC50,2260.11%US$186KSep 30, 2026
Empowered Funds, LLC50,2260.11%US$186KSep 30, 2026
Cerity Partners LLC46,7970.10%US$174KSep 30, 2026

This page holds 50 of 116 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
First Eagle Small Cap Opportunity Fund2.73M5.8%US$9.51MJul 31, 2026
Strategic Advisers U.S. Total Stock Fund1.7M3.6%US$5.2MMay 31, 2026
Vanguard Total Stock Market Index Fund1.25M2.6%US$5.42MJun 30, 2026
iShares Russell 2000 ETF1.12M2.4%US$4.86MJun 30, 2026
Columbia Small Cap Value Discovery Fund689K1.5%US$2.4MJul 31, 2026
Vanguard Extended Market Index Fund482K1.0%US$2.08MJun 30, 2026
Fidelity Small Cap Index Fund465K0.98%US$1.62MJul 31, 2026
iShares Russell 2000 Value ETF392K0.83%US$1.69MJun 30, 2026
iShares Biotechnology ETF280K0.59%US$1.21MJun 30, 2026
Fidelity Extended Market Index Fund231K0.49%US$708KMay 31, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Vanguard Russell 2000 Index Fund213K0.45%US$652KMay 31, 2026
Schwab U.S. Small-Cap ETF207K0.43%US$632KMay 31, 2026
Fidelity Enhanced Small Cap Core ETF200K0.42%US$865KJun 30, 2026
U.S. Micro Cap Portfolio159K0.34%US$554KJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account150K0.32%US$647KJun 30, 2026
iShares Micro-Cap ETF143K0.30%US$619KJun 30, 2026
Vanguard Health Care Index Fund125K0.26%US$381KMay 31, 2026
Columbia Variable Portfolio - Small Cap Value Discovery Fund125K0.26%US$539KJun 30, 2026
Schwab Small-Cap Index Fund104K0.22%US$363KJul 31, 2026
Dimensional U.S. Small Cap ETF104K0.22%US$362KJul 31, 2026
Invesco RAFI US 1500 Small-Mid ETF95,5370.20%US$332KJul 31, 2026
Avantis U.S. Small Cap Equity ETF90,8940.19%US$278KMay 31, 2026
Vanguard Strategic Small-Cap Equity Fund90,6880.19%US$392KJun 30, 2026
AQR Small Cap Multi-Style Fund82,1680.17%US$355KJun 30, 2026
Fidelity Total Market Index Fund78,5440.17%US$240KMay 31, 2026
Master Small Cap Index Series75,8250.16%US$328KJun 30, 2026
Ultra-Small Company Market Fund68,2260.14%US$295KJun 30, 2026
Fidelity Series Total Market Index Fund66,0590.14%US$202KMay 31, 2026
Fidelity Small Cap Value Index Fund59,6660.13%US$258KJun 30, 2026
Nuveen Small Cap Blend Index Fund57,9950.12%US$202KJul 31, 2026
iShares Core S&P Total U.S. Stock Market ETF50,0890.11%US$216KJun 30, 2026
EQ/2000 Managed Volatility Portfolio49,8170.10%US$215KJun 30, 2026
EQ/Small Company Index Portfolio39,5000.08%US$171KJun 30, 2026
Vanguard Russell 2000 Value Index Fund28,1050.06%US$86,001May 31, 2026
Fidelity Nasdaq Composite Index Fund27,8840.06%US$85,325May 31, 2026
LVIP State Street Small-Cap Index Fund26,6000.06%US$115KJun 30, 2026
Schwab U.S. Broad Market ETF26,1470.06%US$80,010May 31, 2026
Vanguard Balanced Index Fund24,5600.05%US$106KJun 30, 2026
BlackRock Advantage SMID Cap Fund, Inc.23,8490.05%US$103KJun 30, 2026
Diversified Equity Alpha Master Portfolio23,7500.05%US$103KJun 30, 2026
Nuveen Equity Index Fund22,8690.05%US$79,584Jul 31, 2026
Fidelity ZERO Total Market Index Fund21,7330.05%US$75,631Jul 31, 2026
Vanguard Institutional Total Stock Market Index Fund21,0880.04%US$91,100Jun 30, 2026
Global X Russell 2000 ETF20,4070.04%US$71,016Jul 31, 2026
Small Cap Index Fund18,0850.04%US$78,127Jun 30, 2026
Small Cap Index Fund17,6400.04%US$53,978May 31, 2026
Bridge Builder Small/Mid Cap Value Fund17,4490.04%US$75,380Jun 30, 2026
Fidelity ZERO Extended Market Index Fund15,2130.03%US$52,941Jul 31, 2026
MetLife Russell 2000 Index Portfolio14,6750.03%US$63,396Jun 30, 2026
EQ/AB Small Cap Growth Portfolio13,9800.03%US$60,394Jun 30, 2026

This page holds 50 of 118 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Donnelly William P
Director
Buy72,245USD 2.93US$212KAug 13, 2026
Donnelly William P
Director
Buy27,155USD 2.75US$74,676Aug 12, 2026
Meadows Benjamin
Officer: Chief Commercial Officer
Buy3,500USD 2.77US$9,695May 12, 2026

Big stakes

StakeStakeSharesDateFiling
Ameriprise Financial Inc7.50%3.54MMar 31, 2026Schedule 13G
BlackRock, Inc.7.30%2.84MJun 30, 2025Schedule 13G
Telegraph Hill Partners III, L.P.5.40%2.5MSep 30, 2025Schedule 13G
Kent Lake PR LLC4.50%2.09MJul 11, 2025Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Paul Meister
Other companies: Versigent PLC (Director · Since at least Apr 1, 2026); Amneal Pharmaceuticals, Inc. (Chairman of the Board · Since at least Aug 2, 2019); Aptiv PLC (Lead Independent Director · Since at least Jul 25, 2019); Oaktree Acquisition Corp. III Life Sciences (Director · Oct 23, 2024 – Oct 23, 2024 · Past); Telesis Bio, Inc. (Director · Jun 5, 2023 – Jun 6, 2023 · Past); Oaktree Acquisition II Corp (Director · Sep 16, 2020 – Sep 16, 2020 · Past); Hims & Hers Health, Inc. (Director · Jul 17, 2019 – Jul 17, 2019 · Past); Revlon Inc (Director · Jun 9, 2016 – Jun 9, 2016 · Past); vTv Therapeutics Inc. (Director · Jul 30, 2015 – Jul 30, 2015 · Past); Light & Wonder, Inc. (Director · Mar 20, 2012 – Jun 10, 2020 · Past); M & F Worldwide Corp (Director · Apr 30, 2007 – Dec 21, 2011 · Past); Thermo Fisher Scientific Inc (Director · Nov 9, 2006 – Jan 5, 2007 · Past); LKQ Corporation (Director · Mar 31, 2006 – May 8, 2017 · Past); Fisher Scientific International Inc (Vice Chairman, Director · Jan 13, 2006 – Nov 9, 2006 · Past)
Director · Since at least Dec 6, 2017
Douglas G Cole
Other companies: Foghorn Therapeutics Inc. (Director · Since at least Oct 22, 2020); Sana Biotechnology, Inc. (Director · Feb 3, 2021 – Jun 6, 2024 · Past); Sigilon Therapeutics Inc (Director · Dec 3, 2020 – Aug 11, 2023 · Past); Denali Therapeutics Inc. (Director · Dec 7, 2017 – Jun 1, 2023 · Past); Editas Medicine, Inc. (Director · Feb 2, 2016 – Aug 17, 2017 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Aug 10, 2016 · Past); Receptos Inc (Director · May 8, 2013 – Jul 17, 2013 · Past); Tetraphase Pharmaceuticals Inc (Director · Mar 19, 2013 – Mar 25, 2013 · Past); AVEO Pharmaceuticals Inc (Director · Mar 11, 2010 – May 12, 2011 · Past)
Director · Dec 6, 2017 – Jan 2, 2019 · Past
Martin Madaus
Other companies: Haemonetics Corporation (Director · Since at least Jul 24, 2026); Hologic Inc (Director · Since at least Dec 6, 2024); Azenta, Inc. (interim President and CEO · Since at least Jan 30, 2024); Repligen Corporation (Chair of the Board · Since at least Feb 6, 2023); Standard BioTools Inc. (Director · Apr 4, 2022 – Oct 20, 2023 · Past); Covidien plc (Director · Dec 1, 2011 – Feb 20, 2014 · Past); Mettler-Toledo International, Inc. (Director · Jul 23, 2009 – Nov 18, 2014 · Past); Millipore Corp (CEO and President, Director · Feb 16, 2006 – Jul 14, 2010 · Past)
Director · Dec 6, 2017 – Jan 2, 2025 · Past
Keith Crandell
Other companies: Kardigan, Inc. (Director · Since at least Jun 22, 2026); Metsera, Inc. (Director · Since at least Nov 13, 2025); 908 Devices Inc. (Director · Since at least Dec 17, 2020); Twist Bioscience Corporation (Co-Founder and Managing Director · Since at least Oct 30, 2018); Da32 Life Science Tech Acquisition Corp (Director · Jul 27, 2021 – Jul 28, 2023 · Past); Adesto Technologies Corporation (Director · Oct 26, 2015 – Jun 4, 2019 · Past); Celebrate Express Inc (Director · Oct 19, 2006 – Aug 29, 2008 · Past)
Director · Dec 6, 2017 – Apr 3, 2023 · Past
Marijn E Dekkers
Other companies: Ginkgo Bioworks Holdings, Inc. (Director · Sep 16, 2021 – Jun 12, 2024 · Past); Quantum-Si Incorporated (Director · Jun 10, 2021 – May 11, 2022 · Past); Cerevel Therapeutics Holdings Inc (Director · Oct 27, 2020 – Aug 1, 2024 · Past); GE Aerospace (Director · Jun 12, 2012 – Apr 2, 2018 · Past); Biogen Inc. (Director · May 31, 2007 – Jun 3, 2009 · Past); Thermo Fisher Scientific Inc (Chief Executive Officer, Director · Jan 7, 2006 – Aug 17, 2009 · Past)
Director · Dec 6, 2017 – Jan 11, 2021 · Past
Everett Cunningham
Other companies: GeneDx Holdings Corp. (Chief Executive Officer and a member of the Board · Since Nov 18, 2026); Illumina, Inc. (SVP, Chief Commercial Officer · Since at least Jun 10, 2024); Arvinas, Inc. (Director · Since at least Dec 15, 2022); EXACT Sciences Corporation (Chief Commercial Officer · Nov 1, 2021 – Apr 30, 2024 · Past); Quest Diagnostics Incorporated (SVP, Commercial · Feb 19, 2018 – Mar 1, 2019 · Past)
President and CEO, Director · Since at least Jan 8, 2026
Karen A. Flynn
Other companies: Stevanato Group S.p.A. (Director · Since at least Mar 18, 2026); Sotera Health Company (Director · Since at least Nov 13, 2023); Catalent Inc (Director · Jan 8, 2020 – Oct 27, 2023 · Past); Recro Pharma Inc (Director · Sep 3, 2015 – Dec 5, 2019 · Past); West Pharmaceutical Services, Inc. (Sr VP & Chief Commercial Offic · Jul 1, 2012 – Feb 19, 2019 · Past)
Director · Since at least Jun 6, 2022
Kevin Hrusovsky
Other companies: 908 Devices Inc. (Director · Since at least Dec 17, 2020); Da32 Life Science Tech Acquisition Corp (Director · Jul 27, 2021 – Jul 27, 2021 · Past); Revvity, Inc. (See Remarks · Feb 1, 2012 – May 31, 2013 · Past); SeraCare Life Sciences Inc (Director · May 10, 2011 – Apr 20, 2012 · Past); Caliper Life Sciences Inc (President & CEO, Director · Mar 3, 2009 – Nov 7, 2011 · Past)
Executive Chairman, Director · Dec 6, 2017 – Jul 5, 2022 · Past
Sarah E Hlavinka
Other companies: ODP Corp (EVP-Chief Legal Officer & Secy · Since at least Jul 9, 2022); Telesis Bio, Inc. (Director · Jul 16, 2024 – Jul 24, 2024 · Past); Itron, Inc. (SVP, Gen. Counsel & Corp. Sec. · Aug 6, 2018 – Feb 24, 2022 · Past); Xerox Holdings Corporation (EVP, Gen. Counsel & Corp. Sec. · Jan 18, 2017 – Apr 6, 2018 · Past); ABM Industries Incorporated (EVP/GEN. COUNSEL/CORP. SECTY. · May 16, 2008 – Jan 14, 2017 · Past)
Director · Since at least Jul 25, 2019
Brian J. Blaser
Other companies: QuidelOrtho Corporation (President and Chief Executive Officer · Since at least May 6, 2024); Talis Biomedical Corp (President and CEO, Director · Dec 1, 2021 – Dec 1, 2021 · Past); Rockley Photonics Holdings Ltd (Director · Aug 11, 2021 – May 17, 2022 · Past); Abbott Laboratories (Executive Vice President · May 17, 2010 – May 23, 2019 · Past)
Director · Jan 6, 2023 – Jan 2, 2024 · Past
All 50 people
PersonSeat
Goldman Myla Lai
Other companies: Akoya Biosciences Inc (Director · Since at least Sep 16, 2021); West Pharmaceutical Services, Inc. (Director · Since at least Feb 18, 2014); Sequenom Inc (Director · Sep 11, 2012 – Sep 7, 2016 · Past); Labcorp Holdings Inc. (EVP & Chief Medical Officer · Jan 5, 2006 – Nov 20, 2008 · Past)
Director · Since at least Jul 8, 2025
Ivana Magovčević-Liebisch
Other companies: Acrivon Therapeutics, Inc. (Director · Since at least Feb 8, 2024); Vigil Neuroscience Inc (President and CEO, Director · Since at least Jan 6, 2022); Absci Corporation (Director · Jul 21, 2021 – Jun 8, 2022 · Past); Spyre Therapeutics, Inc. (Director · Jun 8, 2021 – Jun 22, 2023 · Past)
Director · Since at least Oct 2, 2024
Jeffrey Elliott
Other companies: ICON plc (Director · Since at least Jun 1, 2026); Sera Prognostics, Inc. (Director · Since at least Mar 20, 2025); Exagen Inc. (Director · Sep 18, 2019 – Jun 18, 2020 · Past); EXACT Sciences Corporation (Chief Financial Officer · Nov 8, 2016 – Apr 30, 2024 · Past)
COO of Exact Sciences · Since at least Aug 19, 2024
Scott Mendel
Other companies: Quantum-Si Incorporated (Director · Since at least May 11, 2023); Akoya Biosciences Inc (Director · Since at least Jun 11, 2021); GenMark Diagnostics Inc (President & CEO, Director · May 13, 2014 – Apr 22, 2021 · Past); Active Network Inc (Chief Financial Officer · May 24, 2011 – Nov 15, 2013 · Past)
Director · Since at least Jul 8, 2025
David R Walt
Other companies: Exicure, Inc. (Director · Sep 26, 2017 – Jun 4, 2020 · Past); Dare Bioscience, Inc. (Director · Feb 23, 2015 – Jan 3, 2017 · Past); Illumina, Inc. (Director · Apr 2, 2007 – Apr 7, 2016 · Past)
Director · Since at least Dec 6, 2017
William P. Donnelly
Other companies: T. Rowe Price Group, Inc. (Director · Since at least Nov 1, 2023); Ingersoll Rand Inc. (Lead Independent Director · Since at least May 11, 2017); Mettler-Toledo International, Inc. (Executive Vice President · Apr 19, 2006 – Dec 31, 2018 · Past)
Director · Since at least Aug 17, 2023
Daniel Char
Other companies: ImmunoGen Inc (SVP & CHIEF LEGAL OFFICER · Nov 21, 2022 – Feb 12, 2024 · Past); Evelo Biosciences, Inc. (General Counsel · Oct 29, 2018 – Jul 19, 2022 · Past)
Chief Legal Officer · Since at least Feb 23, 2026
John M Connolly
Other companies: Princeton Review Inc (Chief Executive Officer · Mar 8, 2011 – Apr 8, 2012 · Past); Edgar Online Inc (Director · Jan 28, 2010 – Aug 14, 2012 · Past)
Director · Dec 6, 2017 – Jan 2, 2020 · Past
Joseph Driscoll
Other companies: Akoya Biosciences Inc (Chief Financial Officer · Apr 20, 2021 – Dec 22, 2022 · Past); PC Connection, Inc. (Sr. VP, CFO and Treasurer · Sep 1, 2015 – Sep 1, 2016 · Past)
Chief Financial Officer · Dec 6, 2017 – Jan 15, 2019 · Past
Laurie J Olson
Other companies: Karuna Therapeutics Inc (Director · Aug 12, 2020 – Mar 18, 2024 · Past); Pfizer, Inc. (Executive Vice President · Jul 17, 2012 – Aug 13, 2018 · Past)
Director · Apr 27, 2021 – May 14, 2024 · Past
Malcolm Garret Hampton
Other companies: IDEAYA Biosciences, Inc. (Director · Since at least Jun 26, 2020); Illumina, Inc. (SVP Clinical Genomics Group · Jan 26, 2017 – Jan 9, 2020 · Past)
Director · Since at least Nov 20, 2025
Amee Desjourdy
Other companies: Fortive Corporation (SVP - Chief People Officer · Since at least Jan 26, 2026)
Chief Human Resource Officer · Aug 19, 2019 – Aug 19, 2019 · Past
Amol Chaubal
Other companies: Waters Corporation (SVP & Chief Financial Officer · Since at least May 12, 2021)
Chief Financial Officer · Apr 12, 2019 – May 3, 2021 · Past
Garret Hampton
Other companies: IDEAYA Biosciences, Inc. (Director · Since at least Nov 4, 2026)
Since at least Nov 20, 2025
John J Fry
Other companies: Analogic Corporation (See Remarks · Nov 26, 2007 – Jun 22, 2018 · Past)
General Counsel & Secretary · Jun 14, 2019 – Aug 1, 2022 · Past
Michael A Doyle
Other companies: Forrester Research, Inc. (Chief Financial Officer · Nov 3, 2020 – Dec 14, 2020 · Past)
CFO and Treasurer · Jul 12, 2021 – Sep 30, 2023 · Past
Vandana Sriram
Other companies: Azenta, Inc. (SVP Finance & Corp. Controller · Feb 1, 2022 – Jan 31, 2023 · Past)
Chief Financial Officer · Since at least Aug 21, 2023
William Geist
Other companies: Bio-Techne Corp (PRESIDENT, PROTEIN SCIENCES · Since at least Jan 3, 2022)
Chief Operating Officer · Nov 16, 2020 – Feb 8, 2021 · Past
Alan SachsDirector · Since at least Nov 20, 2025
Amy AchornInvestor Relations · Nov 12, 2024 – Nov 18, 2026 · Past
Anthony CatalanoChief Operating Officer · Since at least Nov 19, 2026
Benjamin MeadowsChief Commercial Officer · Since at least Feb 23, 2026
Bruce J BalVP of Ops, Service and Quality · Dec 6, 2017 – May 10, 2018 · Past
David C DuffySVP R&D and CTO · Dec 6, 2017 – Mar 23, 2022 · Past
Dawn MattoonSr. VP, Diagnostics · Feb 23, 2018 – Apr 1, 2022 · Past
Erica BellChief People Officer · Since at least Nov 19, 2026
Ernest OrticerioSVP Finance and Corporate Dev · Dec 6, 2017 – Jan 9, 2019 · Past
Geoff AlbrechtSenior Vice President and General Manager of Diagnostics · Since Jun 4, 2026 · Appointed, no departure found
Geoff AlbrechtSVP, General Manager, Diagnostics · Since at least Jun 4, 2026
James Edward Gute JrChief Commercial Officer · Since at least Aug 17, 2026
Jason FaesslerChief Financial Officer · Since at least Jun 9, 2026
Jim GuteServe in the additional role of Interim President and CEO · Since Nov 18, 2026 · Appointed, no departure found
Jim GuteChief Commercial Officer and Interim President and CEO · Since at least Aug 10, 2026
Joshua YoungInvestor Relations · Since at least Apr 15, 2026
Mark T RoskeySVP, Strategic Partnerships · Dec 6, 2017 – Apr 1, 2022 · Past
Masoud TolouePresident & CEO, Director · Since at least Jun 9, 2021
Michael MillerChief Technology and Product Officer · Since at least Feb 23, 2026
Naren BhatChief Strategy Officer · Since at least Nov 19, 2026
Shawn StetsonInterim CFO and Treasurer · May 11, 2021 – May 11, 2021 · Past
Yuri FeskoChief Medical Officer · Since at least Sep 14, 2026

Open People

Log in to ask 6ix AI your own questions about Quanterix Corporation.